Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A Study to Learn if 3 Doses of the 20vPnC Vaccine Were Safe in Healthy Infants and if 20vPnC Produced Antibody Responses Against a Germ Called Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
A Study of the Safety of 20vPnC in Healthy Infants
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
A Study to Learn if 20vPnC Vaccine was Safe in Healthy Infants and if 20vPnC Produced Antibody Responses Against a Germ called Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
20vPnC-rokotteen turvallisuutta koskeva tutkimus terveillä lapsilla
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Finnish
ViewDownloadPrint
Hodnocení ke zjištění, zda bylo podání 3 dávek vakcíny 20vPnC u zdravých kojenců bezpečné a zda vakcína 20vPnC vyvolala protilátkovou odpověď na bakterii zvanou Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Czech
ViewDownloadPrint
Et forsøg, der undersøgte, om 3 doser af 20vPnC-vaccinen var sikker hos raske spædbørn, og om 20vPnC dannede antistofresponser mod en bakterie kaldet Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Danish
ViewDownloadPrint
Een studie om te onderzoeken of 3 dosissen van het 20vPnC-vaccin veilig waren bij gezonde zuigelingen en of 20vPnC antilichaamreacties produceerde tegen een ziektekiem met de naam Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Dutch
ViewDownloadPrint
uuring, mille eesmärk on uurida, kas kolm annust 20vPnC vaktsiini on tervetel imikutel ohutu ja kas 20vPnC tekitab antikehareaktsiooni mikroobi Streptococcus pneumoniae vastu
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Estonian
ViewDownloadPrint
Tutkimus, jossa selvitetään, olivatko kolme 20vPnC-rokoteannosta turvallisia terveillä vauvoilla ja saavutettiinko 20vPnC-rokotteella vasta-ainevasteita Streptococcus pneumoniae -bakteereille
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Finnish
ViewDownloadPrint
Étude sur la sécurité d’emploi et l’immunogénicité du vaccin 20vPnC en série de 3 doses chez des nourrissons en bonne santé contre un germe appelé Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: French
ViewDownloadPrint
Eine Studie, in der untersucht wurde, ob 3 Dosen des 20vPnC-Impfstoffs bei gesunden Säuglingen sicher waren und ob 20vPnC zur Bildung von Antikörpern gegen den Krankheitserreger Streptococcus pneumoniae führte
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: German
ViewDownloadPrint
Uno studio per verificare se 3 dosi del vaccino 20vPnC fossero sicure in neonati sani e se il 20vPnC producesse risposte anticorpali contro un germe chiamato Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: Italian
ViewDownloadPrint